The Cerebral Palsies—Using a Common Language in Research Allows New Insights

Ingeborg Krägeloh-Mann

doi:10.1055/s-0040-1708513

Neuropediatrics, Inhaltsverzeichnis

Neuropediatrics 2020; 51(02): 087-088
DOI: 10.1055/s-0040-1708513

Editorial

Georg Thieme Verlag KG Stuttgart · New York

The Cerebral Palsies—Using a Common Language in Research Allows New Insights

Ingeborg Krägeloh-Mann

¹Department of Paediatric Neurology and Developmental Medicine, University Children's Hospital, Tübingen, Germany

References
1 Surveillance of Cerebral Palsy in Europe. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol 2000; 42 (12) 816-824
2 Moreno-De-Luca A, Ledbetter DH, Martin CL. Genetic [corrected] insights into the causes and classification of [corrected] cerebral palsies. Lancet Neurol 2012; 11 (03) 283-292
3 Platt MJ, Cans C, Johnson A. , et al. Trends in cerebral palsy among infants of very low birthweight (<1500 g) or born prematurely (<32 weeks) in 16 European centres: a database study. Lancet 2007; 369 (9555): 43-50
4 Sellier E, Platt MJ, Andersen GL, Krägeloh-Mann I, De La Cruz J, Cans C. ; Surveillance of Cerebral Palsy Network. Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003. Dev Med Child Neurol 2016; 58 (01) 85-92
5 Sellier E, McIntyre S, Smithers-Sheedy H, Platt MJ. on behalf of SCPE and the ACPR Group. European and Australian cerebral palsy surveillance networks working together for collaborative research. Neuropediatrics 2020; 51 (02) 105-112
6 Korzeniewski SJ, Slaughter J, Lenski M, Haak P, Paneth N. The complex aetiology of cerebral palsy. Nat Rev Neurol 2018; 14 (09) 528-543
7 Horber V, Sellier E, Horridgen K. , et al. The origin of the cerebral palsies: contribution of population-based neuroimaging data. Neuropediatrics 2020; 51 (02) 113-119
8 Corbett MA, van Eyk CL, Webber DL. , et al. Pathogenic copy number variants that affect gene expression contribute to genomic burden in cerebral palsy. NPJ Genom Med 2018; 3: 33
9 Horber V, Fares A, Platt MJ, Arnaud C, Krägeloh-Mann I, Sellier E. on behalf of the SCPE. Severity of cerebral palsy—the impact of associated impairments. Neuropediatrics 2020; 51 (02) 120-128
10 Himmelmann K, Påhlman M, Andersen GL. , et al. Access to intrathecal baclofen treatment for children with cerebral palsy in European countries: an SCPE survey reveals important differences. Neuropediatrics 2020; 51 (02) 129-134
11 Franki I, Bar-On L, Molenaers G. , et al. Tone reduction and physical therapy: strengthening partners in treatment of children with spastic cerebral palsy. Neuropediatrics 2020; 51 (02) 89-104